A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure
Title | Posted | Study ID | Phase | Status | Sponsor |
---|---|---|---|---|---|
2007/06/29 | Phase 3 | Completed | |||
2000/02/25 | Phase 3 | Completed | National Center for Research Resources (NCRR) |
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|---|---|---|---|---|
Keveyis | Strongbridge US Inc. | ORAL | 50 mg in 1 1 | 2021/12/13 | 71090-001 |
Dichlorphenamide | ORAL | 50 mg in 1 1 | 2023/01/05 | 13668-676 | |
Dichlorphenamide | ORAL | 50 mg in 1 1 | 2023/03/09 | 72065-002 |
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No Singapore products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
双氯非那胺片 | 国药准字H31020561 | 片剂 | N/A | 25mg | Chemical Drug | Approved | 2020/08/19 | Domestic |
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No Australia products found for this drug